Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

被引:410
|
作者
Takahashi, Yoshihisa [1 ]
Soejima, Yurie [1 ]
Fukusato, Toshio [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
关键词
Animal model; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Histopathology; ACTIVATED-RECEPTOR-ALPHA; CHOLINE-DEFICIENT DIET; METHIONINE ADENOSYLTRANSFERASE 1A; FRUCTOSE-ENRICHED DIETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DB/DB MICE; HEPATIC INFLAMMATION; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I
10.3748/wjg.v18.i19.2300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2300 / 2308
页数:9
相关论文
共 50 条
  • [21] Characterization of diet based nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in rodent models: Histological and biochemical outcomes
    Akbari, Ghaidafeh
    Mard, Seyyed Ali
    Savari, Feryal
    Barati, Barat
    Sameri, Maryam Jafar
    HISTOLOGY AND HISTOPATHOLOGY, 2022, 37 (09) : 813 - 824
  • [22] Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
    Sayiner, Mehmet
    Koenig, Aaron
    Henry, Linda
    Younossi, Zobair M.
    CLINICS IN LIVER DISEASE, 2016, 20 (02) : 205 - +
  • [23] Histopathology of nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Tiniakos, Dina G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (42) : 5286 - 5296
  • [24] Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
    Alam, Shahinul
    Noor-E-Alam, Sheikh Mohammad
    Chowdhury, Ziaur Rahman
    Alam, Mahabubul
    Kabir, Jahangir
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (05) : 281 - 287
  • [25] Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
    Shahinul Alam
    Sheikh Mohammad Noor-E-Alam
    Ziaur Rahman Chowdhury
    Mahabubul Alam
    Jahangir Kabir
    World Journal of Hepatology, 2013, (05) : 281 - 287
  • [26] Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Esterson, Yonah B.
    Grimaldi, Gregory M.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 93 - +
  • [27] Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis
    Qamar, Amir A.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 : S28 - S32
  • [28] Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management
    Kim, Soo Ki
    Kim, Ke Ih
    Kim, Soo Ryang
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (09): : 1147 - 1153
  • [29] Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Amjad, Waseem
    Shalaurova, Irina
    Garcia, Erwin
    Gruppen, Eke G.
    Dullaart, Robin P. F.
    DePaoli, Alex M.
    Jiang, Z. Gordon
    Lai, Michelle
    Connelly, Margery A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)